Effects of Thoracic Paravertebral Block Combined With S-ketamine on Postoperative Pain and Cognitive Function After Thoracoscopic Surgery
Postoperative Cognitive Dysfunction
About this trial
This is an interventional prevention trial for Postoperative Cognitive Dysfunction focused on measuring Esketamine, Thoracic paravertebral block, Cognitive function
Eligibility Criteria
Inclusion Criteria:
- 18-24kg/m2
- American Society of Anesthesiologists (ASA) grades I-III
- The score of Mini Mental state examination≥24
Exclusion Criteria:
- Patients with heart, lung and other vital organ disorders
- The score of Mini Mental state examination≤23
- Preoperative psychiatric disorders or long-term use of drugs affecting the psychiatric system
- Have severe visual, hearing, speech impairment or other inability to communicate with the visitor
- Refuse to sign informed consent
Sites / Locations
- The First hosptial of Qinhuangdao
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Other
Experimental
Experimental
Other
Group C
Group TA
Group TE
Non-surgical controls
The general anesthesia was used.In this group, cognitive function was evaluated by MMSE scale on one day before surgery, one day after surgery, and three months after surgery
Group TA received 0.375% ropivacaine 20ml thoracic paravertebral nerve block combined with general anesthesia under ultrasound guidance after anesthesia induction
Group TE received s-ketamine anesthesia induction dose of 0.3 mg/kg on the basis of TA group. Anesthesia maintenance dose of 0.2ug/kg/h was pumped to 30min before the end of the operation
Age and sex-matched community people are included for three sessions of MMSE test evaluation for calculation of POCD incidence as normal control to in Z value calculation of POCD incidence to rule out learning effect